January 21, 2025 - 21:35

A recent analysis has placed Connecticut as one of the least favorable states for launching a new business, ranking it second to last in the nation. The evaluation, conducted by WalletHub, assessed all 50 states using 25 different indicators that contribute to startup success.
According to WalletHub, the challenges of starting a business in Connecticut are significant, particularly in the context of the current economic climate. The high cost of living and doing business in the state adds to the daunting reality that nearly half of all new businesses fail within their first five years.
Entrepreneurs considering Connecticut may face hurdles such as expensive commercial real estate, high taxes, and a competitive market. These factors contribute to an environment that can be intimidating for aspiring business owners. As the landscape for startups continues to evolve, potential entrepreneurs in Connecticut will need to weigh these challenges carefully against their ambitions.
August 7, 2026 - 01:20
Virginia businesses sue to block new THC regulations set to take effect this monthA group of Virginia business owners has filed a lawsuit to stop new state regulations on hemp products that are scheduled to kick in later this month. The rules, which take effect on August 16,...
August 6, 2026 - 23:17
Cardiologists share vaccine recommendations for heart patients: Flu, COVID-19 and moreThe American College of Cardiology has released updated guidance stressing that vaccination is a critical part of care for anyone living with cardiovascular disease. The new recommendations cover...
August 6, 2026 - 02:06
Amazon, Avril, Ferguson team up for housing as questions hang over WA's business climateSeattle`s given me a lot, Avril said. For me, it was all about just being able to pour back into the city that`s given me so much. That sentiment now anchors a new partnership between Amazon, the...
August 5, 2026 - 18:08
Clopidogrel monotherapy bests aspirin when patients with diabetes undergo PCIA fresh look at data from the SMART-CHOICE 3 trial suggests that diabetic patients who receive a coronary stent may do better on clopidogrel alone than on aspirin alone, once the standard initial...